Prime solutions for cardiopulmonary bypass in neonates: antioxidant capacity of prime based on albumin or fresh frozen plasma. 2001

J S Molicki, and A M Draaisma, and N Verbeet, and R Munneke, and H A Huysmans, and M G Hazekamp, and H M Berger
Department of Pediatrics, Division of Neonatology, Leiden University Medical Center, Leiden, The Netherlands.

OBJECTIVE Oxidative damage and inflammation are believed to play an important role in postoperative complications after cardiopulmonary bypass. During bypass, a prime solution with a high antioxidant capacity may reduce the oxidative damage and inflammation. We investigated total antioxidant capacity and individual scavengers during the preparation of 2 different prime solutions. METHODS The prime solutions were prepared with either pasteurized human albumin or fresh frozen plasma. The total antioxidant capacity was measured with the total radical antioxidant parameter assay and with the ferric-reducing ability of plasma assay. The individual scavengers vitamin C, sulfhydryl groups, uric acid, and total protein were measured before, during, and after the prime preparation. Malondialdehyde was measured as a parameter for lipid peroxidation. RESULTS Neither prime solution showed a total radical antioxidant parameter value. The ferric-reducing ability of plasma value of prime solutions was lower than that of undiluted human albumin or fresh frozen plasma. Addition of mannitol did not increase the ferric-reducing ability of plasma value. Vitamin C was only found in the fresh frozen plasma prime. Both prime solutions contained sulfhydryl groups and uric acid in low concentrations. During ultrafiltration, low-molecular-weight antioxidants were lost into the ultrafiltrate. CONCLUSIONS We showed that prime solutions based on either albumin or fresh frozen plasma had very low antioxidant capacity and that ultrafiltration of the prime solution further lowers this capacity. A prime solution with a low antioxidant capacity may increase oxidative stress in neonates undergoing cardiopulmonary bypass.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D009017 Morbidity The proportion of patients with a particular disease during a given year per given unit of population. Morbidities
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002314 Cardioplegic Solutions Solutions which, upon administration, will temporarily arrest cardiac activity. They are used in the performance of heart surgery. Cardioplegic Solution,Solution, Cardioplegic,Solutions, Cardioplegic
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug

Related Publications

J S Molicki, and A M Draaisma, and N Verbeet, and R Munneke, and H A Huysmans, and M G Hazekamp, and H M Berger
January 2020, American journal of clinical and experimental immunology,
J S Molicki, and A M Draaisma, and N Verbeet, and R Munneke, and H A Huysmans, and M G Hazekamp, and H M Berger
November 1983, The Annals of thoracic surgery,
J S Molicki, and A M Draaisma, and N Verbeet, and R Munneke, and H A Huysmans, and M G Hazekamp, and H M Berger
August 1988, Anesthesiology,
J S Molicki, and A M Draaisma, and N Verbeet, and R Munneke, and H A Huysmans, and M G Hazekamp, and H M Berger
May 2021, Perfusion,
J S Molicki, and A M Draaisma, and N Verbeet, and R Munneke, and H A Huysmans, and M G Hazekamp, and H M Berger
October 2018, Paediatric anaesthesia,
J S Molicki, and A M Draaisma, and N Verbeet, and R Munneke, and H A Huysmans, and M G Hazekamp, and H M Berger
January 1966, Transfusion,
J S Molicki, and A M Draaisma, and N Verbeet, and R Munneke, and H A Huysmans, and M G Hazekamp, and H M Berger
October 2021, Journal of cardiothoracic and vascular anesthesia,
J S Molicki, and A M Draaisma, and N Verbeet, and R Munneke, and H A Huysmans, and M G Hazekamp, and H M Berger
June 1984, The Annals of thoracic surgery,
J S Molicki, and A M Draaisma, and N Verbeet, and R Munneke, and H A Huysmans, and M G Hazekamp, and H M Berger
May 2024, Journal of cardiothoracic and vascular anesthesia,
J S Molicki, and A M Draaisma, and N Verbeet, and R Munneke, and H A Huysmans, and M G Hazekamp, and H M Berger
September 2009, Paediatric anaesthesia,
Copied contents to your clipboard!